These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 9844122)

  • 21. Vitamin D in inflammatory diseases.
    Wöbke TK; Sorg BL; Steinhilber D
    Front Physiol; 2014; 5():244. PubMed ID: 25071589
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diabetic kidney disease: from physiology to therapeutics.
    Mora-Fernández C; Domínguez-Pimentel V; de Fuentes MM; Górriz JL; Martínez-Castelao A; Navarro-González JF
    J Physiol; 2014 Sep; 592(18):3997-4012. PubMed ID: 24907306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 25 (OH) vitamin D levels and renal disease progression in patients with type 2 diabetic nephropathy and blockade of the renin-angiotensin system.
    Fernández-Juárez G; Luño J; Barrio V; de Vinuesa SG; Praga M; Goicoechea M; Lahera V; Casas L; Oliva J;
    Clin J Am Soc Nephrol; 2013 Nov; 8(11):1870-6. PubMed ID: 24135218
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Racial differences in the association of serum 25-hydroxyvitamin D concentration with coronary heart disease events.
    Robinson-Cohen C; Hoofnagle AN; Ix JH; Sachs MC; Tracy RP; Siscovick DS; Kestenbaum BR; de Boer IH
    JAMA; 2013 Jul; 310(2):179-88. PubMed ID: 23839752
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The influence of selective vitamin D receptor activator paricalcitol on cardiovascular system and cardiorenal protection.
    Duplancic D; Cesarik M; Poljak NK; Radman M; Kovacic V; Radic J; Rogosic V
    Clin Interv Aging; 2013; 8():149-56. PubMed ID: 23430986
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting the hepcidin-ferroportin axis to develop new treatment strategies for anemia of chronic disease and anemia of inflammation.
    Sun CC; Vaja V; Babitt JL; Lin HY
    Am J Hematol; 2012 Apr; 87(4):392-400. PubMed ID: 22290531
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum 25-hydroxyvitamin D and change in estimated glomerular filtration rate.
    de Boer IH; Katz R; Chonchol M; Ix JH; Sarnak MJ; Shlipak MG; Siscovick DS; Kestenbaum B
    Clin J Am Soc Nephrol; 2011 Sep; 6(9):2141-9. PubMed ID: 21836148
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Active vitamin D and acute respiratory infections in dialysis patients.
    Tsujimoto Y; Tahara H; Shoji T; Emoto M; Koyama H; Ishimura E; Tabata T; Nishizawa Y; Inaba M
    Clin J Am Soc Nephrol; 2011 Jun; 6(6):1361-7. PubMed ID: 21617088
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of 25-hydroxyvitamin D deficiency in promoting insulin resistance and inflammation in patients with chronic kidney disease: a randomised controlled trial.
    Petchey WG; Hickman IJ; Duncan E; Prins JB; Hawley CM; Johnson DW; Barraclough K; Isbel NM
    BMC Nephrol; 2009 Dec; 10():41. PubMed ID: 20003316
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Administration of alfacalcidol for patients with predialysis chronic kidney disease may reduce cardiovascular disease events.
    Sugiura S; Inaguma D; Kitagawa A; Murata M; Kamimura Y; Sendo S; Hamaguchi K; Nagaya H; Tatematsu M; Kurata K; Yuzawa Y; Matsuo S
    Clin Exp Nephrol; 2010 Feb; 14(1):43-50. PubMed ID: 19882205
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vitamin D deficiency and anemia: a cross-sectional study.
    Sim JJ; Lac PT; Liu IL; Meguerditchian SO; Kumar VA; Kujubu DA; Rasgon SA
    Ann Hematol; 2010 May; 89(5):447-52. PubMed ID: 19841921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bone and mineral disorders in pre-dialysis CKD.
    Kovesdy CP; Kalantar-Zadeh K
    Int Urol Nephrol; 2008; 40(2):427-40. PubMed ID: 18368510
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vitamin K and vitamin D status: associations with inflammatory markers in the Framingham Offspring Study.
    Shea MK; Booth SL; Massaro JM; Jacques PF; D'Agostino RB; Dawson-Hughes B; Ordovas JM; O'Donnell CJ; Kathiresan S; Keaney JF; Vasan RS; Benjamin EJ
    Am J Epidemiol; 2008 Feb; 167(3):313-20. PubMed ID: 18006902
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nonclassical aspects of differential vitamin D receptor activation: implications for survival in patients with chronic kidney disease.
    Andress D
    Drugs; 2007; 67(14):1999-2012. PubMed ID: 17883284
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Calcitriol modulates in vivo and in vitro cytokine production: a role for intracellular calcium.
    Panichi V; De Pietro S; Andreini B; Bianchi AM; Migliori M; Taccola D; Giovannini L; Tetta C; Palla R
    Kidney Int; 1998 Nov; 54(5):1463-9. PubMed ID: 9844122
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased production of interleukin-1beta and interleukin-1 receptor antagonist by peripheral blood mononuclear cells in undialyzed chronic renal failure.
    Higuchi T; Yamamoto C; Kuno T; Mizuno M; Takahashi S; Kanmatsuse K
    Nephron; 1997; 76(1):26-31. PubMed ID: 9171296
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma lipopolysaccharide binding protein and bactericidal/permeability increasing factor in CRF and HD patients.
    Pereira BJ; Sundaram S; Snodgrass B; Hogan P; King AJ
    J Am Soc Nephrol; 1996 Mar; 7(3):479-87. PubMed ID: 8704115
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of dialyzer membrane on interleukin-1beta (IL-1beta) and IL-1beta-converting enzyme in mononuclear cells.
    Linnenweber S; Lonnemann G
    Kidney Int Suppl; 2001 Feb; 78():S282-5. PubMed ID: 11169027
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Influence of erythropoietin on immunological system of patients with chronic renal failure].
    Debska-Slizień A; Rutkowski B; Manitius J; Zdrojewski Z; Szołkiewicz M; Bułło B; Lizakowski S; Myśliwska J; Myśliwski A; Bryl E; Trzonkowski P; Bakowska A; Rachoń D
    Pol Merkur Lekarski; 2003 Oct; 15(88):326-7; discussion 327-9. PubMed ID: 14974359
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.